These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
249 related items for PubMed ID: 16195688
1. Chronic angina: new medical options for treatment. McCullough PA. Rev Cardiovasc Med; 2005; 6(3):152-61. PubMed ID: 16195688 [Abstract] [Full Text] [Related]
4. Metabolic efficiency with ranolazine for less ischemia in non-ST elevation acute coronary syndromes (MERLIN TIMI-36) study. Melloni C, Newby LK. Expert Rev Cardiovasc Ther; 2008 Jan; 6(1):9-16. PubMed ID: 18095903 [Abstract] [Full Text] [Related]
5. The use of partial fatty acid oxidation inhibitors for metabolic therapy of angina pectoris and heart failure. Rupp H, Zarain-Herzberg A, Maisch B. Herz; 2002 Nov; 27(7):621-36. PubMed ID: 12439634 [Abstract] [Full Text] [Related]
6. Metabolic manipulation in ischaemic heart disease, a novel approach to treatment. Lee L, Horowitz J, Frenneaux M. Eur Heart J; 2004 Apr; 25(8):634-41. PubMed ID: 15084367 [Abstract] [Full Text] [Related]
7. Anti-ischemic effects and long-term survival during ranolazine monotherapy in patients with chronic severe angina. Chaitman BR, Skettino SL, Parker JO, Hanley P, Meluzin J, Kuch J, Pepine CJ, Wang W, Nelson JJ, Hebert DA, Wolff AA, MARISA Investigators. J Am Coll Cardiol; 2004 Apr 21; 43(8):1375-82. PubMed ID: 15093870 [Abstract] [Full Text] [Related]
8. The antianginal agent trimetazidine does not exert its functional benefit via inhibition of mitochondrial long-chain 3-ketoacyl coenzyme A thiolase. MacInnes A, Fairman DA, Binding P, Rhodes Ja, Wyatt MJ, Phelan A, Haddock PS, Karran EH. Circ Res; 2003 Aug 08; 93(3):e26-32. PubMed ID: 12869391 [Abstract] [Full Text] [Related]
9. Chronic angina and the treatment with ranolazine: facts and recommendations. Milne HC, Vallerand AH. Prog Cardiovasc Nurs; 2009 Sep 08; 24(3):90-5. PubMed ID: 19737166 [Abstract] [Full Text] [Related]
16. Ranolazine: a new option in the management of chronic stable angina. Dobesh PP, Trujillo TC. Pharmacotherapy; 2007 Dec 07; 27(12):1659-76. PubMed ID: 18041887 [Abstract] [Full Text] [Related]
17. Clinical benefits of a metabolic approach with trimetazidine in revascularized patients with angina. Danchin N. Am J Cardiol; 2006 Sep 04; 98(5A):8J-13J. PubMed ID: 16931200 [Abstract] [Full Text] [Related]
18. Ranolazine: a new approach to management of patients with angina. Tafreshi MJ, Fisher E. Ann Pharmacother; 2006 Apr 04; 40(4):689-93. PubMed ID: 16595572 [Abstract] [Full Text] [Related]
19. Antianginal efficacy of ranolazine when added to treatment with amlodipine: the ERICA (Efficacy of Ranolazine in Chronic Angina) trial. Stone PH, Gratsiansky NA, Blokhin A, Huang IZ, Meng L, ERICA Investigators. J Am Coll Cardiol; 2006 Aug 01; 48(3):566-75. PubMed ID: 16875985 [Abstract] [Full Text] [Related]
20. Novel drugs for treating angina. Jones DA, Timmis A, Wragg A. BMJ; 2013 Sep 09; 347():f4726. PubMed ID: 24018101 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]